AXIM (AXIM Biotechnologies) Other Current Liabilities: $4.24 Mil (As of Jun. 2025)


What is AXIM Biotechnologies Other Current Liabilities?

AXIM Biotechnologies AXIM Other Current Liabilities is $4.24 Mil as of Jun. 2025. The stock has 7 warning signs investors should review.

AXIM Biotechnologies's other current liabilities for the quarter that ended in Jun. 2025 was $4.24 Mil.

AXIM Biotechnologies's quarterly other current liabilities increased from Dec. 2024 ($4.12 Mil) to Mar. 2025 ($4.12 Mil) and increased from Mar. 2025 ($4.12 Mil) to Jun. 2025 ($4.24 Mil).

AXIM Biotechnologies's annual other current liabilities increased from Dec. 2022 ($1.65 Mil) to Dec. 2023 ($2.48 Mil) and increased from Dec. 2023 ($2.48 Mil) to Dec. 2024 ($4.12 Mil).

AXIM Biotechnologies Other Current Liabilities Related Terms

AXIM Biotechnologies Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies Other Current Liabilities Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 1.65 2.48 4.12

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.49 4.12 4.12 4.12 4.24

AXIM Biotechnologies Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $4.24 Mil mean?
AXIM Biotechnologies (AXIM) has a Other Current Liabilities of $4.24 Mil as of Jun. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on AXIM Biotechnologies.
Is AXIM Biotechnologies' Other Current Liabilities too high?
AXIM Biotechnologies' current Other Current Liabilities is $4.24 Mil.
How does AXIM Biotechnologies' Other Current Liabilities compare to HEPA and SCNI?
AXIM Biotechnologies' Other Current Liabilities of $4.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on AXIM Biotechnologies. AXIM Biotechnologies's current Other Current Liabilities is $4.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Other Current Liabilities of $4.24 Mil. The current Other Current Liabilities is $4.24 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Other Current Liabilities is $4.24 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.